Stuart re: BIPH,
I hope I'm not being to liberal in connecting these dots; but it sure is interesting that Biophan/Nanoset just discovered (and patented) how their nanomagnetic coatings have drug-eluting properties, while doing R&D with Boston Scientific, who has 75% market share in drug-eluting stents.
Even more interesting to me is that they presented this information during a panel discussion with ANPI today, who is BSXs current liscensor of the drug-eluting tech. for the Taxus stent. If nothing else, the joint-presentation with ANPI at least validates BIPHs claims. But I really think BIPH and ANPI might have a bit more of a relationship/colaboration under the veil of BSX non-disclosure agreements.
I don't know why the market didn't get a little more excited about it; but I sure am.
I'll stop chearleading for now.....and wait patiently for the day when the BSX R&D becomes more transparent.
Good luck!
"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854